BACKGROUND AND STUDY AIMS: Conventional plastic stents with a lumen typically have limited patency. The lumenless wing stent was engineered to overcome this problem. The objective of this study was to compare the incidence of early stent occlusion (symptomatic occlusion/cholangitis necessitating re-insertion within 90 days) for wing stents and conventional plastic stents. PATIENTS AND METHODS: Patients with biliary pathology treated with plastic biliary stenting during the period 2003-2009 comprised the study cohort. Patients who had at least one biliary wing stent placed comprised the wing stent group, whereas patients who underwent only conventional stent plastic placement comprised the conventional stent group. Patients were stratified by indication: benign biliary strictures (group 1), malignant biliary strictures (group 2), or benign biliary non-stricture pathology (group 3). The association of stent type with the occurrence of primary outcome by indication was analyzed by use of multivariable logistic regression. RESULTS: Three-hundred and forty-six patients underwent 612 ERCP procedures with placement of plastic biliary stent(s). On multivariate analysis, early stent occlusion did not differ between the wing and conventional groups in groups 1, 2, and 3. Among patients who achieved primary outcome in group 2, significantly fewer patients in the wing group had cholangitis (6.7% vs. 39.1%, P = 0.03). Among patients who achieved primary outcome in group 3, significantly fewer patients in the wing group had cholangitis (10% vs. 50%, P = 0.03). CONCLUSIONS: Early stent occlusion was similar for wing stents and conventional plastic stents. Wing stents, however, were associated with a lower incidence of cholangitis in patients with malignant biliary obstruction and benign non-stricturing biliary pathology.
BACKGROUND AND STUDY AIMS: Conventional plastic stents with a lumen typically have limited patency. The lumenless wing stent was engineered to overcome this problem. The objective of this study was to compare the incidence of early stent occlusion (symptomatic occlusion/cholangitis necessitating re-insertion within 90 days) for wing stents and conventional plastic stents. PATIENTS AND METHODS: Patients with biliary pathology treated with plastic biliary stenting during the period 2003-2009 comprised the study cohort. Patients who had at least one biliary wing stent placed comprised the wing stent group, whereas patients who underwent only conventional stent plastic placement comprised the conventional stent group. Patients were stratified by indication: benign biliary strictures (group 1), malignant biliary strictures (group 2), or benign biliary non-stricture pathology (group 3). The association of stent type with the occurrence of primary outcome by indication was analyzed by use of multivariable logistic regression. RESULTS: Three-hundred and forty-six patients underwent 612 ERCP procedures with placement of plastic biliary stent(s). On multivariate analysis, early stent occlusion did not differ between the wing and conventional groups in groups 1, 2, and 3. Among patients who achieved primary outcome in group 2, significantly fewer patients in the wing group had cholangitis (6.7% vs. 39.1%, P = 0.03). Among patients who achieved primary outcome in group 3, significantly fewer patients in the wing group had cholangitis (10% vs. 50%, P = 0.03). CONCLUSIONS: Early stent occlusion was similar for wing stents and conventional plastic stents. Wing stents, however, were associated with a lower incidence of cholangitis in patients with malignant biliary obstruction and benign non-stricturing biliary pathology.
Authors: A M van Berkel; C Boland; W K Redekop; J J Bergman; A K Groen; G N Tytgat; K Huibregtse Journal: Endoscopy Date: 1998-10 Impact factor: 10.093
Authors: G Costamagna; M Mutignani; G Rotondano; L Cipolletta; L Ghezzo; A Foco; A Zambelli Journal: Gastrointest Endosc Date: 2000-01 Impact factor: 9.427
Authors: Marc F Catalano; Joseph E Geenen; Glen A Lehman; Jerome H Siegel; Leslie Jacob; Matthew J McKinley; Isaac Raijman; Peter Meier; Ira Jacobson; Richard Kozarek; Firas H Al-Kawas; Simon K Lo; Kulwinder S Dua; John Baille; Gregory G Ginsberg; William Parsons; Scott M Meyerson; Seth Cohen; Douglas B Nelson; James D McHattie; David L Carr-Locke Journal: Gastrointest Endosc Date: 2002-03 Impact factor: 9.427
Authors: Anne-Marie van Berkel; Inge L Huibregtse; Jacques J G H M Bergman; Erik A J Rauws; Marco J Bruno; Kees Huibregtse Journal: Eur J Gastroenterol Hepatol Date: 2004-02 Impact factor: 2.566
Authors: Lachlan Ayres; Danny Cheriyan; Ryan Scott; Edward Kim; Terry Lee; Joel Singer; Fergal Donnellan; Michael Byrne; Alan Weiss; Robert Enns; Jack Amar; Eric Lam; Jennifer Telford Journal: Endosc Int Open Date: 2017-07-06